Sign in

CIK 0001600620 · Large accelerated filer

Aurinia Pharmaceuticals Inc.

Sign in to watch
Ticker
AUPH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
981231763
Phone
250-744-2487
Business address
#140, 14315 - 118 AVENUE, EDMONTON, Alberta, Canada, T5L 4S6
  1. SC 13G/A Stake Amended Statement of Ownership
  2. SC 13G Stake Amended Statement of Ownership
  3. SC 13D/A Stake Beneficial Ownership Report
  4. 6-K Event Report of Foreign Issuer
  5. 6-K Event Report of Foreign Issuer
  6. SC 13D/A Stake Beneficial Ownership Report
  7. SUPPL Other SUPPL
  8. 6-K Event Report of Foreign Issuer
  9. SUPPL Other SUPPL
  10. 6-K Event Report of Foreign Issuer
  11. SC 13D/A Stake Beneficial Ownership Report
  12. SC 13D/A Stake Beneficial Ownership Report
  13. 6-K Event Report of Foreign Issuer
  14. 6-K Event Report of Foreign Issuer
  15. 6-K Event Report of Foreign Issuer
  16. 6-K Event Report of Foreign Issuer
  17. SC 13D/A Stake Beneficial Ownership Report
  18. 6-K Event Report of Foreign Issuer
  19. 6-K Event Report of Foreign Issuer
  20. 6-K Event Report of Foreign Issuer

Page 20 of 31 · 615 filings